Company maintained the 2013 Stock Incentive Plan (as amended, the “2013 Equity Plan”), under which the Company’s employees, officers, and directors were awarded various types of share-based compensation, including options to purchase shares of the Company’s class A common stock, restricted stock units, and other stock-based awards. In
May 2023
, the 2013 Equity Plan expired and no new awards may be granted under the 2013 Equity Plan, although awards previously granted under the 2013 Equity Plan will continue to remain outstanding in accordance with their terms.
The Company maintains the 2023 Equity Incentive Plan (as amended, the “2023 Equity Plan”) under which the Company’s employees, officers, directors, and other eligible participants may be awarded various types of share-based compensation, including options to purchase shares of the Company’s class A common stock, restricted stock units, performance stock units, and other stock-based awards. An aggregate of up to
19,327,030
shares of the Company’s class A common stock were authorized for issuance under the 2023 Equity Plan. As of
March 31, 2025, there were
2,768,783
shares of class A common stock reserved and available for future issuance under the 2023 Equity Plan. The 2013 Equity Plan and the 2023 Equity Plan together are referred to herein as the “Stock Incentive Plans.”
Stock option awards
As of March 31, 2025, there were options to purchase
4,560,073
shares of class A common stock outstanding under the Stock Incentive Plans.
The following table summarizes the Company’s stock option activity (in thousands, except per share data and years) for the
three months ended March 31, 2025:
Stock options outstanding as of
March 31, 2025 are comprised of the following range of exercise prices per share (in thousands, except per share data and years):
17
An aggregate of
958,570
stock options with an aggregate grant date fair value of $
30.2
million vested during the three months ended March 31, 2025
.
The weighted average grant date fair value of stock option awards using the Black-Scholes valuation model was $
221.70
and $
111.44
for each share subject to a stock option granted during the
three months ended March 31, 2025 and 2024, respectively, based on the following assumptions:
For the three months ended March 31, 2025 and 2024, the Company recognized approximately $
6.6
million and $
9.8
million, respectively, in share-based compensation expense from stock options granted under the Stock Incentive Plans. As of March 31, 2025, there was approximately $
35.0
million of total unrecognized share-based compensation expense related to unvested stock options, which the Company expects to recognize over a weighted average vesting period of approximately
2.4
years.
Share-settled restricted stock units
As of March 31, 2025, there were
1,145,722
share-settled restricted stock units outstanding under the Stock Incentive Plans.
The following table summarizes the Company’s share-settled restricted stock unit